A method for interdicting the development of severe jaundice in newborns by inhibiting the production of bilirubin.
Kappas
Attallah
A
Rockefeller University Hospital, New York, New York, USA. kappas@rockefeller.edu
D001663:Bilirubin / Q000096:biosynthesis*; D004791:Enzyme Inhibitors / Q000627:therapeutic use*; D005260:Female; D006419:Heme Oxygenase (Decyclizing) / Q000037:antagonists & inhibitors*; D006801:Humans; D007231:Infant, Newborn; D007567:Jaundice, Neonatal / Q000188:drug therapy* / Q000628:therapy; D008665:Metalloporphyrins / Q000627:therapeutic use*; D010789:Phototherapy; D016032:Randomized Controlled Trials as Topic
D004791:Enzyme Inhibitors; D008665:Metalloporphyrins; C055421:tin mesoporphyrin; D006419:Heme Oxygenase (Decyclizing); D001663:Bilirubin